BACKGROUND: Integrin alphaIIbbeta3 mediates platelet adhesion and aggregation and plays a crucial role in thrombosis and hemostasis. alphaIIbbeta3 is expressed in a low affinity state on resting platelets. Upon platelet activation, alphaIIbbeta3 shifts to a high affinity conformation that efficiently binds its ligands. On human platelets, the high affinity conformation of alphaIIbbeta3 is detected by the monoclonal antibody (mAb), PAC-1. However, a reagent with binding specificity to high affinity mouse alphaIIbbeta3 has not been described so far. METHODS: A novel rat mAb directed against mouse alphaIIbbeta3 (JON/A) was generated and characterized. JON/A was conjugated with fluorescein isothiocyanate (JON/A(FITC)) or with R-phycoerythrin (JON/A(PE)) and used for flow cytometric analysis of mouse platelets. RESULTS: Although JON/A(FITC) bound to resting and activated platelets, virtually no binding of the larger JON/A(PE) to resting platelets was detectable. However, strong binding of JON/A(PE) occurred on platelet activation in a dose-dependent manner. Binding of JON/A(PE) required extracellular free calcium and was irreversible, thereby stabilizing the high affinity conformation of alphaIIbbeta3. CONCLUSION: JON/A(PE) is the first tool for direct assessment of integrin alphaIIbbeta3 activation in mice. Furthermore, JON/A(FITC) and JON/A(PE) provide the first examples of fluorescent antibody derivatives with identical antigenic specificity that allow the discrimination between the resting and the activated state of an integrin. Copyright 2002 Wiley-Liss, Inc.
BACKGROUND: Integrin alphaIIbbeta3 mediates platelet adhesion and aggregation and plays a crucial role in thrombosis and hemostasis. alphaIIbbeta3 is expressed in a low affinity state on resting platelets. Upon platelet activation, alphaIIbbeta3 shifts to a high affinity conformation that efficiently binds its ligands. On human platelets, the high affinity conformation of alphaIIbbeta3 is detected by the monoclonal antibody (mAb), PAC-1. However, a reagent with binding specificity to high affinity mouse alphaIIbbeta3 has not been described so far. METHODS: A novel rat mAb directed against mouse alphaIIbbeta3 (JON/A) was generated and characterized. JON/A was conjugated with fluorescein isothiocyanate (JON/A(FITC)) or with R-phycoerythrin (JON/A(PE)) and used for flow cytometric analysis of mouse platelets. RESULTS: Although JON/A(FITC) bound to resting and activated platelets, virtually no binding of the larger JON/A(PE) to resting platelets was detectable. However, strong binding of JON/A(PE) occurred on platelet activation in a dose-dependent manner. Binding of JON/A(PE) required extracellular free calcium and was irreversible, thereby stabilizing the high affinity conformation of alphaIIbbeta3. CONCLUSION: JON/A(PE) is the first tool for direct assessment of integrin alphaIIbbeta3 activation in mice. Furthermore, JON/A(FITC) and JON/A(PE) provide the first examples of fluorescent antibody derivatives with identical antigenic specificity that allow the discrimination between the resting and the activated state of an integrin. Copyright 2002 Wiley-Liss, Inc.
Authors: Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer Journal: EMBO J Date: 2012-06-22 Impact factor: 11.598
Authors: Renata Polanowska-Grabowska; Kori Wallace; Joshua J Field; Lanlin Chen; Melissa A Marshall; Robert Figler; Adrian R L Gear; Joel Linden Journal: Arterioscler Thromb Vasc Biol Date: 2010-11-11 Impact factor: 8.311
Authors: Moritz Stolla; Lucia Stefanini; R Claire Roden; Massiel Chavez; Jessica Hirsch; Teshell Greene; Timothy D Ouellette; Sean F Maloney; Scott L Diamond; Mortimer Poncz; Donna S Woulfe; Wolfgang Bergmeier Journal: Blood Date: 2010-10-22 Impact factor: 22.113
Authors: Lucia Stefanini; Feng Ye; Adam K Snider; Kasra Sarabakhsh; Raymond Piatt; David S Paul; Wolfgang Bergmeier; Brian G Petrich Journal: Blood Date: 2014-02-28 Impact factor: 22.113
Authors: Wolfgang Bergmeier; Crystal L Piffath; Tobias Goerge; Stephen M Cifuni; Zaverio M Ruggeri; Jerry Ware; Denisa D Wagner Journal: Proc Natl Acad Sci U S A Date: 2006-10-30 Impact factor: 11.205
Authors: Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola Journal: Blood Date: 2005-08-16 Impact factor: 22.113
Authors: Matthias Canault; Daniel Duerschmied; Alexander Brill; Lucia Stefanini; Daphne Schatzberg; Stephen M Cifuni; Wolfgang Bergmeier; Denisa D Wagner Journal: Blood Date: 2009-11-30 Impact factor: 22.113